Videos

Patients share their emotional journeys and coping strategies after cancer diagnoses, highlighting the importance of support and information in healing.

Following a multiple myeloma diagnosis, care partners describe an initial wave of fear and logistical stress.

This panel of multiple myeloma care partners shares diverse diagnostic journeys, offering vital insights for patients and caregivers.

Patients share their unexpected journeys with multiple myeloma, revealing challenges and resilience in the face of a cancer diagnosis.

An expert discusses IL-18-armored CAR T cells for adults with relapsed B-cell leukemia, showing complete remissions with manageable side effects.

CURE spoke with a clinical psychologist about the stigmas often faced by patients with lung cancer.

Dan describes how early self-advocacy, second opinions and trial research helped him pursue experimental treatments that led to remission from stage 4 pancreatic cancer.

Jace Yawnick, now in remission from non-Hodgkin lymphoma, is navigating the world of mental health one day at a time.

Gastric cancer care highlights eating difficulties, weight loss and side effects showing why nutrition support and clinical trials are key

After beginning treatment for stage 3 inflammatory breast cancer, Lindsey Gunter started experiencing chemotherapy side effects so intense she was unable to walk.

Bleximenib and Venclexta treatment were well tolerated in a phase 1b trial for relapsed/refractory acute myeloid leukemia with mostly low-grade side effects.

Asian women who do not smoke in Northern California face rising lung cancer rates which are often diagnosed late due to current screening gaps.

Emmy-winning journalist and author Suleika Jaouad recently delivered the keynote address at the inaugural Blood Cancer Heroes celebration.

Emmy-winning journalist and author, Suleika Jaouad, delivered the keynote address at the inaugural Blood Cancer Heroes event.

In a recent interview with CURE, Dr. Kai Tsao discussed treatment advancements for patients with prostate cancer.

Dr. Robert Orlowski says a single-drug option in newly diagnosed myeloma may offer strong responses with fewer side effects and preserve future treatments.

CURE spoke with a Mayo Clinic expert about the current status of breast cancer vaccines.

Although great strides have been made in research for breast cancer vaccines, such a vaccine is likely years away from commercial availability.

A Mayo Clinic Expert Corrected Some Common Misconceptions Regarding Breast Cancer Vaccines

Real-time text check-ins helped physicians identify issues sooner and support quality of life for patients with myeloma at ASH 2025.

Dr. Thomas Marron explains how therapeutic vaccines differ from preventative vaccines in lung cancer care.

Dr. Amany Keruakous discussed how bispecific antibodies for multiple myeloma work by simultaneously targeting cancer cells and T cells.

Dr. Ajay Gupta of the Roswell Park Comprehensive Cancer Center discussed basics of gastrointestinal stromal tumors.

Dr. Daniel Peters discussed targeted therapies and regimens that patients with acute myeloid leukemia, or AML, should be aware of.

Dr. Girindra Raval sat down for an interview with CURE to discuss what patients with EGFR-mutated lung cancer should know about their treatment options.

Nona Baker, who was first diagnosed with a blood cancer in 1991, shares her experience with polycythemia vera.

Dr. Charles M. Rudin discussed recent treatment advancements for patients with small cell lung cancer.

Cindy and Katie share how finding a friend who understood the caregiving journey made the experience less isolating and helped them navigate loss and hope.

An expert explained what patients newly diagnosed with gastrointestinal stromal tumors need to know.

Cell therapies, which have made waves in the treatment of blood cancer, are showing potential for solid tumors.